US2016123916A1PendingUtilityA1

Small Volume In Vitro Analyte Sensor

Assignee: ABBOTT DIABETES CARE INCPriority: Feb 6, 1997Filed: Jan 11, 2016Published: May 5, 2016
Est. expiryFeb 6, 2017(expired)· nominal 20-yr term from priority
C12Q 1/006G01N 27/3272G01N 2333/904A61B 5/14532A61B 5/1411C12Q 1/004A61B 5/150022A61B 5/150412A61B 2560/0223A61B 2562/0295G01N 33/5438A61B 5/150503A61B 5/14546A61B 5/1486A61B 5/14865A61B 5/15144C12Q 1/001A61B 5/1495A61B 5/15113G01N 27/3273A61B 5/15105A61B 5/157A61B 5/150358
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than about 1 μL. The sensor has a working electrode coated with a non-leachable redox mediator. The redox mediator acts as an electron transfer agent between the analyte and the electrode. In addition, a second electron transfer agent, such as an enzyme, can be added to facilitate the electrooxidation or electroreduction of the analyte. The redox mediator is typically a redox compound bound to a polymer. The preferred redox mediators are air-oxidizable. The amount of analyte can be determined by coulometry. One particular coulometric technique includes the measurement of the current between the working electrode and a counter or reference electrode at two or more times. The charge passed by this current to or from the analyte is correlated with the amount of analyte in the sample. Other electrochemical detection methods, such as amperometric, voltammetric, and potentiometric techniques, can also be used. The invention can be used to determine the concentration of a biomolecule, such as glucose or lactate, in a biological fluid, such as blood or serum. An enzyme capable of catalyzing the electrooxidation or electroreduction of the biomolecule is provided as a second electron transfer agent.

Claims

exact text as granted — not AI-modified
1 - 132 . (canceled) 
     
     
         133 . A method for determining a concentration of glucose in a blood sample from a patient, comprising the steps of:
 transporting a blood sample of the patient into a sample chamber of a test strip, the sample chamber comprising a first electrode comprising a glucose responsive enzyme and a second electrode, wherein the sample chamber has a volume of 1 μl or less; and   determining the concentration of the glucose in the blood sample by measuring the charge passed through the first electrode over a period of time of within 1 minute after transporting the blood sample.   
     
     
         134 . The method of  claim 133 , wherein the sample chamber has a volume of 0.5 μl or less. 
     
     
         135 . The method of  claim 133 , wherein the sample chamber has a volume of 0.2 μl or less. 
     
     
         136 . The method of  claim 133 , wherein the sample chamber has a volume of 0.1 μl or less. 
     
     
         137 . The method of  claim 133 , wherein the sample chamber comprises the first electrode and the second electrode in a facing orientation. 
     
     
         138 . The method of  claim 133 , wherein the sample chamber comprises the first electrode and the second electrode in a co-planer orientation. 
     
     
         139 . The method of  claim 133 , wherein the glucose responsive enzyme is immobilized on the first electrode. 
     
     
         140 . The method of  claim 133 , wherein the glucose responsive enzyme is glucose oxidase or glucose dehydrogenase. 
     
     
         141 . The method of  claim 133 , wherein the test strip further includes a redox mediator disposed on the first electrode. 
     
     
         142 . The method of  claim 141 , wherein the redox mediator is immobilized on the first electrode. 
     
     
         143 . The method of  claim 141 , wherein the redox mediator is an air-oxidizable redox mediator. 
     
     
         144 . The method of  claim 141 , wherein the redox mediator carries electrons directly to the first electrode. 
     
     
         145 . The method of  claim 141 , wherein the redox mediator comprises an osmium complex, a ferrocyanide, or a ferricyanide. 
     
     
         146 . The method of  claim 133 , wherein the sample chamber comprises a third electrode. 
     
     
         147 . The method of  claim 133 , wherein the first electrode comprises gold, carbon, platinum, ruthenium dioxide or palladium. 
     
     
         148 . The method of  claim 133 , wherein the first electrode is separated from the second electrode by a distance of less than 200 micrometer.

Join the waitlist — get patent alerts

Track US2016123916A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.